The upregulation of Bcl-2 is often involved in MDR, and the concurrent upregulation of P-gp and Bcl-2 has been previously described in samples obtained from patients with AML and acute lymphoblasticleukemia (ALL) [52,53]. Here, BCL2 is linked to acute myeloid leukemia.